Twitter Facebook LinkedIn YouTube

Alliance Growers (CSE:ACG) is in the final stage of negotiations with WFS Pharmagreen

Video Platform Video Management Video Solutions Video Player

Alliance Growers is in the final stage of its previously announced negotiations with WFS Pharmagreen, a private company located in Mission, British Columbia. Alliance is close to announcing terms of a planned $300,000 equity investment into Canna Companion Products, a wholly owned subsidiary of WFS PharmaGreen.

Additional Information:

Company: Alliance Growers
Website: http://www.alliancegrowers.com
Stock Symbol: CSE: ACG
Date Published: Nov 16, 2016
Transcript: Available

Video Transcript:

I’m Samantha Deutscher for Investmentpitch Media

Alliance Growers is in the final stage of its previously announced negotiations with WFS Pharmagreen, a private company located in Mission, British Columbia.

Alliance is close to announcing terms of a planned $300,000 equity investment into Canna Companion Products, a wholly owned subsidiary of WFS PharmaGreen.

Canna Companion, based in Washington State, operates a 5,000 square foot facility for the production and distribution of cannabinoid infused pet products.

As part of the arrangement, Alliance will enter into a long-term contract to provide cannabinoid oil to Canna Companions when it enters the Canadian market, which is expected in 2017.

Dennis Petke, President and CEO stated: “We are very proud of the achievements to date that Alliance Growers has accomplished toward our goal of becoming a truly global cannabis company. We have multiple CBD oil supply contracts and potential investments with growers under negotiation within North America and in other countries. In addition to Alliance Growers providing services and plantlets to growers of all sizes, it is our vision to become the leading supplier of pharmaceutical grade CBD oil globally through long term supply contracts.”
.
Alliance previously announced that it had been granted a license from Botanical Research in Motion International, to jointly develop and operate multiple Botany Centres in Canada.

The terms of the license allow Alliance Growers to market and distribute all present and future Tissue Culture plantlet products utilizing BRIM’s proprietary “Chibafreen Invitro Plant Production System” technology.

This technology is critical to the mass production of disease-free, genetically identical, healthy starting plant material.

Alliance and BRIM plan to jointly develop and operate a 40,000 square foot facility to be the first of its kind in Western Canada to house a DNA Botany lab.

To finance the development of the cannabis focused Botany Centre, the company has engaged DGWA, the German Institute for Asset and Equity Allocation and Valuation, one of the leading German Corporate Boutiques providing financial advisory services to global small and mid-cap companies.

This venture will be assisted upon receipt of approval of its pending Frankfurt Stock Exchange listing.

The company also announced a non-brokered private placement of up to 10 million units at a price of $0.20 per unit, for gross proceeds of up to $2,000,000.

Each unit is comprised of one common share and one warrant, with each warrant exercisable at $0.30 per share, for a period of two years.

The shares are currently trading at $0.30, and with 33 million shares outstanding, the company is capitalized at $9.9 million.

For more information, please visit the company’s website, www.alliancegrowers.com,
contact Dennis Petke, President & CEO, at 778-331-4266 or email DennisPetke@AllianceGrowers.com.